Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZKY001 eye drops for corneal epithelial defects after TPRK
CTR20220901Phase 2Completed
- Sponsor
- Zhaoke Pharmaceutical (Hefei) Co., Ltd.
- Start
- Apr 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of germinal peptide in Corneal epithelial defect, sponsored by Zhaoke Pharmaceutical (Hefei) Co., Ltd.. Started Apr 2022; status: completed.
02
Drugs
germinal peptide
03
Conditions
Corneal epithelial defect
Beyond the preview
Go deeper on CTR20220901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220901.